Rapid Barostat Bag (RBB) Pump and Catheter System
Mui Scientific, Inc. · Decision date Sep 30, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on September 30, 2026 for the Rapid Barostat Bag (RBB) Pump and Catheter System, submitted by Mui Scientific, Inc. of Mississauga, Ontario, under 510(k) number K262621. The device falls under regulation 876.1725 with product code FFX, in the Gastroenterology/Urology specialty, and the application was received July 28, 2026. A SESE decision is a 510(k) clearance, not a PMA approval.
The review letter describes the submission as covering changes that included replacing certain components and suppliers with equivalent alternatives to reduce risk and improve efficiency, along with minor design changes. The available excerpts do not identify which components or suppliers were replaced, the specific design changes, or the predicate device relied upon; the summary document itself was not reviewed here. No clinical performance, efficacy or patient-selection information is established by this record.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Sep 30, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262621
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Mui Scientific, Inc.
- Product code
- FFX
- Decision code
- SESE
- Decision date
- Sep 30, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, Gastrointestinal Motility (Electrical).
- Applicant
- Mui Scientific, Inc.
- Product code
- FFX
- FDA device class
- 2
FDA decision timeline
K262621 received
Application receipt date recorded by FDA.
K262621 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Mui Scientific, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Mississauga
Sources and methodology
- Original FDA record: K262621
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records